Drug Shortage Report for YERVOY
Report ID | 167674 |
Drug Identification Number | 02379384 |
Brand name | YERVOY |
Common or Proper name | Ipilimumab |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | MARKETED |
Active Ingredient(s) | IPILIMUMAB |
Strength(s) | 5MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1X40ml |
ATC code | L01XC |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-11-07 |
Actual start date | |
Estimated end date | 2023-04-30 |
Actual end date | 2023-03-07 |
Shortage status | Resolved |
Updated date | 2023-03-08 |
Company comments | This shortage only impacts the 200mg and not the 50mg |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2023-03-08 | French | Compare |
v13 | 2023-03-08 | English | Compare |
v12 | 2022-11-08 | English | Compare |
v11 | 2022-11-04 | French | Compare |
v10 | 2022-11-04 | English | Compare |
v9 | 2022-08-24 | French | Compare |
v8 | 2022-08-24 | English | Compare |
v7 | 2022-08-24 | English | Compare |
v6 | 2022-08-24 | French | Compare |
v5 | 2022-08-24 | English | Compare |
v4 | 2022-08-24 | French | Compare |
v3 | 2022-08-24 | English | Compare |
v2 | 2022-08-24 | French | Compare |
v1 | 2022-08-24 | English | Compare |
Showing 1 to 14 of 14